CTCs Show Promise as a Diagnostic Tool in Lung Cancer

News   Mar 22, 2017 | Original story from ASTRO

 
CTCs Show Promise as a Diagnostic Tool in Lung Cancer
 
 
 

RELATED ARTICLES

New Rapid Test for Valley Fever Should Help Reduce Diagnosis Delays

News

November saw a spike if cases of Valley fever. Fortunately, the recent—and timely—approval of a new rapid assay test for Valley fever should reduce delays in diagnosing the respiratory fungal infections—a frequent problem in treating the disease, which is caused by spores endemic to soils in the U.S. Southwest.

READ MORE

Inflammation Causes Chemo Brain

News

The research could lead to a new practice of identifying inflammatory biomarkers in cancer patients and then treating the inflammation with medications or exercise to improve cognition and other symptoms.

READ MORE

Blood Sample Detection Method for Multiple Sclerosis Discovered

News

A method for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research team. The process will avoid the invasive, painful process of collecting fluid from the brain and spine

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE